Replimune enters $250M at-the-market equity agreement with Leerink, cancels prior $100M ATM

Replimune Group, Inc.

New Sales Agreement with Leerink Partners allows sale of up to $250M of common stock via ATM or negotiated transactions.
Agent commission up to 3% of gross proceeds; Company controls timing and size of sales.
Prior $100M ATM program terminated concurrently with the new agreement.
No shares sold yet; Company may issue none under the new facility.
Registration statement on Form S-3 filed same day for the offering.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

Replimune Group, Inc. terminated 2022 Sales Agreement with Leerink Partners LLC valued at terminated (effective 2023-08-03).

Action: termination
Agreement: atm program
Counterparty: Leerink Partners LLC
Value: terminated
Effective: 2023-08-03

Exact text from the filing

Pursuant to the Sales Agreement, the parties mutually agreed to terminate that certain sales agreement, dated June 23, 2022, by and between the Company and the Agent (as amended, the “2022 Sales Agreement”) with respect to the Company’s previous at-the-market offering program (the “2022 ATM Program”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

Replimune Group, Inc. entered into Sales Agreement with Leerink Partners LLC valued at $250,000,000 (effective 2023-08-03).

Action: entry
Agreement: atm program
Counterparty: Leerink Partners LLC
Value: $250,000,000
Effective: 2023-08-03

Exact text from the filing

On August 3, 2023, Replimune Group, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Leerink Partners LLC (formerly known as SVB Securities LLC) (the “Agent”), pursuant to which the Company may sell, from time to time, at its option, up to an aggregate of $250.0 million of shares of the Company’s common stock, $0.001 par value per share (the “Shares”), through the Agent, as the Company’s sales agent.

View on SEC.gov

39 material agreements filed in the last 30 days. Browse all material agreements →

Replimune Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-087083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.